Biocence Trademark Details
Word Mark | Biocence |
---|---|
Status | Alive Registered 700 — Registered |
Serial Number | 77842866 |
---|---|
Registration Number | 4071102 |
Status Date | Tuesday, December 13, 2011 |
Filing Date | Tuesday, December 13, 2011 |
Registration Date | Tuesday, December 13, 2011 |
Attorney | William J. Benman |
Correspondent
WILLIAM J. BENMAN
2049 CENTURY PARK E STE 2740
LOS ANGELES CA 90067-3239
2049 CENTURY PARK E STE 2740
LOS ANGELES CA 90067-3239
Case File Statements
Goods & Services | Chemical preservatives for use in the production of a wide variety of chemicals, Preservatives for pharmaceutical preparations; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating Bacillus anthracis, Anthrax, Bacillus cereus, B. cereus food poisoning, Clostridium botulinum, Botulism, Clostridium perfringens, Clostridialmyonecrosis (gas gangrene), Clostridium tetani, Tetanus (lockjaw), Corynebacteriuni diphtheria, Diphtheria, Escherichia coli, Diarrhea, Klebsiella pneumonia, Bronchopneumonia, Legionellapneumophila, Legionnaire's disease, Mycobacterium leprae, Leprosy, Mycobacteriumtuberculosis, Tuberculosis, Salmonella species, Salmonella, Salmonella typhi, Typhoid fever, Salmonella typhimurium, Salmonella gastroenteritis, Shigella dysenteriae, Bacillary dysentery, Shigella species, Shigellosis, Yersinia enterocolitica, Yersiniosis, gastroenteritis, Yersiniapestis, Plague, Yersinia pseudotuberculosis, Mesenteric lymphadenitis, Chlamydia, Chlamydiatrachomatis, Trachoma, urethritis, cervicitis, conjunctivitis, Bordetella pertussis, (whooping cough), Brucella species, Undulant fever, Hemophilus influenza, Meningitis, bacterial pneumonia, Hemophilus pertussis, (whooping cough), Neisseria gonorrhoeae, Gonorrhea, pelvicinflammatory disease, Neisseria meningitides, Meningitis, Staphylococcus aureus, Pneumonia, toxic shock syndrome, skin infections, meningitis, Streptococcus pneumonia, Pneumonia, ear infections, meningitis, Streptococcus pyogenes, Strep throat, rheumatic fever, Streptococcusspecies, Scarlet fever, puerperal fever, Listeria monocytogenes, Listeriosis, perinatal septicemia, meningitis, encephalitis, intrauterine infections, Mycoplasma pneumonia, Pneumonia, Rickettsia prowazekii, Epidemic typhus, Brill-Zinsser disease (spread by lice), Rickettsiarickettsii, Rocky Mountain spotted fever (spread by ticks), Rickettsia typhi, Endemic typhus (murine typhus, spread by rat fleas), Campylobacter fetus jejuni, Campylobacteriosis (bacterial diarrheal illness), Spirillum minor, Rat-bite fever, Spirochete Treponema pallidum, Syphilis, Aeromonas hydrophila, Gastroenteritis, septicemia, cellulitis, wound infections, urinary tractinfections, Plesiomonas shigelloides, Gastroenteritis, diarrhea, Vibrio cholerae 01, Epidemiccholera, Vibrio cholerae 01, Gastroenteritis, Vibrio parahemolyticus, V. parahemolyticus associated gastroenteritis, Vibrio vulnificus, Wound infections, gastroenteritis, primarysepticemia, Shigella flexneri, S. dysenteria, Vibrio cholera, Salmonella typhi, Salmonella, Enterotoxigenic Escherichia coli, Enterococcus faecalis, B. anthracis Pseudomonas aeruginosa, Mycobacterium chelonae, Candida albicans, Campylobacter, Mycobacterium tuberculosis, Diarrhoeal diseases, respiratory tract infections, meningitis, sexually transmitted infections, Streptococcus pneumoniae, vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, multi-resistant salmonellae, Clostridium difficile and multi-resistant Mycobacterium, tuberculosis and emerging Infectious Diseases, Virucidal disease and conditions of Influenza, Bird HiNI HIIY, herpes simplex virus type 1 and type 2, AvianFlu, Foot and Mouth disease, Ebola virus, Pox virus, Smallpox virus, Talfan disease virus, Sindbis virus, Adenovirus (Common cold), Bunyavirus, Hantaan, La Crosse, Sin Nombre (Kidney failure), Encephalitis (brain infection), Lung syndrome, Calicivirus Norwalk Gastroenteritis (diarrhea, vomiting), Coronavirus (Corona Common cold), Filovirus Ebola, Marburg Hemorrhagic (fever), Hemorrhagic (fever), Flavivirus Hepatitis C (non-A, non-B): Yellow fever (Hepatitis), Hepatitis, hemorrhage, Hepadnavirus Hepatitis B virus (I-IBV), Hepatitis, liver carcinoma, Herpesvirus, Cytomegalovirus, Epstein-Barr virus (EBV), Herpes simplex type 1, Herpes simplex type 2, Human herpesvirus 8 (HHV8), Varicella-zoster, Birthdefects, Mononucleosis, nasopharyngeal carcinoma, Cold sores, Genital lesions, Kaposi'ssarcoma, Chicken pox, shingles, Orthomyxovirus, Influenza types A and B Flu, Papovavirus, Human papillomavirus (ITPV), Warts, cervical carcinoma, Picornavirus, Coxsackie virus, Echovirus, Hepatitis A, Poliovirus, Rhinovirus, Myocarditis (heart muscle infection), Meningitis, Infectious hepatitis, Poliomyelitis, Common cold, Paramyxovirus, Measles, Mumps, Parainfluenza, Measles, Mumps, ear infections, Parvovirus, B 19 Fifth disease, chronic anemia, Poxvirus Orthopoxvirus Smallpox (eradicated), Reovirus Rotavirus, Diarrhea, Retrovirus, Human immunodeficiency virus (HIV), Human T-cell leukemia virus, (HTLV-l), Acquiredimmunodeficiency syndrome (AIDS), Adult T-cell leukemia, lymphoma, neurologic disease, Rhabdovirus, Rabies, Togavirus, Eastern equine encephalomyelitis, Encephalitis, Rubella, and birth defects |
---|---|
Pseudo Mark | Bio Sense |
Classifications
International Class Codes |
001
|
---|---|
U.S. Class Codes | 001, 005, 006, 010, 026, 046 |
Status | 6 — Active |
Status Date | Wednesday, October 14, 2009 |
First Use Anywhere | Thursday, January 17, 2008 |
First Use In Commerce | Thursday, January 17, 2008 |
Primary Code | 001 |
Trademark Timeline
-
Jan 17 2008First use anywhere for the mark
-
Jan 17 2008First use in commerce for the mark
-
Oct 06 2009Trademark application filed with USPTO
-
Oct 09 2009New Application Entered In Tram
-
Oct 14 2009New Application Office Supplied Data Entered In Tram
-
Oct 15 2009Notice of Pseudo Mark Mailed
-
Jan 05 2010Assigned To Examiner
-
Jan 07 2010Non-Final Action Written
-
Jan 08 2010Non-Final Action Mailed
-
Feb 24 2010Applicant/correspondence Changes (non-Responsive) Entered
-
Feb 24 2010Teas Change of Owner Address Received
-
Jul 09 2010Paper Received
-
Jul 20 2010Amendment From Applicant Entered
-
Jul 20 2010Correspondence Received In Law Office
-
Jul 20 2010Assigned To Lie
-
Jul 21 2010Final Refusal Mailed
-
Jul 21 2010Final Refusal Written
-
Feb 16 2011Abandonment Notice Mailed - Failure To Respond
-
Feb 16 2011Abandonment - Failure To Respond Or Late Response
-
Feb 22 2011Reinstatement Granted - Inadvertently Abandoned
-
Feb 23 2011Approved For Pub - Principal Register
-
Feb 23 2011Amendment From Applicant Entered
-
Feb 23 2011Correspondence Received In Law Office
-
Feb 24 2011Law Office Publication Review Completed
-
Feb 25 2011Notice of Reinstatement Mailed
-
Mar 09 2011Notice of Publication
-
Mar 29 2011Published For Opposition
-
May 24 2011Noa Mailed - Sou Required From Applicant
-
Oct 21 2011Use Amendment Filed
-
Oct 21 2011Teas Statement of Use Received
-
Oct 24 2011Case Assigned To Intent To Use Paralegal
-
Oct 27 2011Statement of Use Processing Complete
-
Nov 02 2011Assigned To Examiner
-
Nov 03 2011Allowed Principal Register - Sou Accepted
-
Nov 07 2011Law Office Registration Review Completed
-
Nov 08 2011Notice of Acceptance of Statement of Use Mailed
-
Dec 13 2011Registered-Principal Register
-
Dec 13 2011Trademark officially registered with the USPTO
-
Sep 06 2012Paper Received
-
Sep 25 2012Post Registration Action Mailed No Response Required